DS
NERV icon

DRW Securities’s Minerva Neurosciences NERV Stock Holding History

DRW Securities’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,583
Closed -$147K – 346
2019
Q4 		$147K Hold
2,583
– – 0.01% 215
2019
Q3 		$160K Sell
2,583
-2,500
-49% -$142K 0.01% 129
2019
Q2 		$229K Buy
+5,083
New +$254K 0.01% 96

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAI
Index Venture Associates IV St. Helier, Channel Islands, Jersey $6.24M AUM
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DRW Securities's NERV Position: Q1 2020 in Review

DRW Securities sold out of Minerva Neurosciences (NERV) in Q1 2020, closing a stake of 2,583 shares — an estimated $147K sold.

DRW Securities first reported a position in NERV in Q2 2019 and held it in 3 quarters. The position peaked at $229K in Q2 2019. 90 funds tracked by Wall St. Rank hold NERV as of Q1 2020.

  • DRW Securities reported no remaining Minerva Neurosciences position as of Q1 2020 after selling out during the quarter.
  • DRW Securities sold 2,583 Minerva Neurosciences shares in Q1 2020, an estimated $147K.
  • DRW Securities first reported a position in Minerva Neurosciences in Q2 2019 and held it in 3 quarters.
  • DRW Securities's Minerva Neurosciences position peaked at $229K in Q2 2019.
  • 90 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2020.

Based on DRW Securities's 13F filing for Q1 2020, filed 13 May 2020.